Aixinlir sodium fructose diphosphate on April 24, 2003

Aixinlir (sodium fructose diphosphate) on April 24, 2003

This product is a tonic for myocardial ischemia and systemic tissue ischemia, promoting cellular metabolism, accelerating tissue repair, restoring normal cardiac function, and increasing energy utilization. The basic function of these effects is to enhance red blood cell adaptability and maintain cellular oxygen release capacity. Suitable for various types of myocardial ischemia caused by heart disease, as well as ischemia and shock caused by peripheral vascular occlusion, and systemic cellular ischemia in critically ill patients. Dosage: 50 mL : 5 g, intravenous drip, once daily.